{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:34:54Z","timestamp":1789518894024,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.psychres.2019.112659","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T12:20:03Z","timestamp":1572265203000},"page":"112659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Can epigenetic biomarkers lead us to precision medicine in predicting treatment response and remission for patients being considered for ECT?"],"prefix":"10.1016","volume":"284","author":[{"given":"Tami","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagy A.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psychres.2019.112659_bib0001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/YCT.0000000000000141","article-title":"Epigenetic effects of electroconvulsive seizures","volume":"30","author":"de Jong","year":"2014","journal-title":"J. Ect"},{"issue":"8","key":"10.1016\/j.psychres.2019.112659_bib0002","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S146114571400039X","article-title":"Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response","volume":"17","author":"Domschke","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2019.112659_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103026","article-title":"DNA methylation as a biomarker of treatment response variability in serious mental illnesses: a systematic review focused on bipolar disorder, schizophrenia, and major depressive disorder","volume":"19","author":"Goud Alladi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2019.112659_bib0004","unstructured":"Hyman, S.E., & Krystal, J. (2018). Report of the National advisory mental health council workgroup on genomics. Retrieved from. https:\/\/www.nimh.nih.gov\/about\/advisory-boards-and-groups\/namhc\/reports\/report-of-the-national-advisory-mental-health-council-workgroup-on-genomics.shtml."},{"issue":"6","key":"10.1016\/j.psychres.2019.112659_bib0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-014-1336-6","article-title":"BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy","volume":"122","author":"Kleimann","year":"2015","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.psychres.2019.112659_bib0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/pcn.12634","article-title":"Epigenetics applied to psychiatry: clinical opportunities and future challenges","volume":"72","author":"Kular","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2019.112659_bib0007","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.psychres.2015.05.071","article-title":"The role of epigenetics in depression and suicide: a platform for gene-environment interactions","volume":"228","author":"Lockwood","year":"2015","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.psychres.2019.112659_bib0008","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0006-3223(00)00848-9","article-title":"Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients","volume":"48","author":"Maayan","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2019.112659_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41398-017-0077-3","article-title":"P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy","volume":"8","author":"Neyazi","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112659_bib0010","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1038\/tp.2013.73","article-title":"DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP","volume":"3","author":"Powell","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112659_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neubiorev.2016.10.031","article-title":"Understanding epigenetic architecture of suicide neurobiology: a critical perspective","volume":"72","author":"Roy","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2019.112659_bib0012","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jad.2017.12.010","article-title":"HTR1A\/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients","volume":"228","author":"Wang","year":"2018","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psychres.2019.112659_sbref0012","series-title":"Personal. Med. Psychiatry","article-title":"Precision ECT for major depressive disorder: A review of clinical factors, laboratory, and physiologic biomarkers as predictors of response and remission","author":"Yao","year":"2019"},{"issue":"1","key":"10.1016\/j.psychres.2019.112659_bib0014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1027\/0227-5910\/a000280","article-title":"Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder","volume":"36","author":"Youssef","year":"2015","journal-title":"Crisis"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119317858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119317858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:42:30Z","timestamp":1759038150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178119317858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":14,"alternative-id":["S0165178119317858"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112659","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can epigenetic biomarkers lead us to precision medicine in predicting treatment response and remission for patients being considered for ECT?","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112659"}}